Estrogen Receptor {alpha} and Aromatase Polymorphisms Affect Risk, Prognosis, and Therapeutic Outcome in Men with Castration-Resistant Prostate Cancer Treated with Docetaxel-Based Therapy -- Sissung et al. 96 (2): E368 Data Supplement - Supplemental Data -- Journal of Clinical Endocrinology & Metabolism


Estrogen Receptor ${alpha}$ and Aromatase Polymorphisms Affect Risk, Prognosis, and Therapeutic Outcome in Men with Castration-Resistant Prostate Cancer Treated with Docetaxel-Based Therapy J Clin Endocrinol Metab Sissung et al. 96: E368 Supplemental Data Supplemental Data Files in this Data Supplement: Supplemental Data - Table 1